脂酶PLA2G7是GPX4的补充剂,可以减轻前列腺癌细胞中基酸诱导的铁亡
Perrine Vermonden1, Manon Martin1, Katarzyna Glowacka2
1Louvain Institute of Biomolecular Science and Technology, UCLouvain, 1348 Louvain-la-Neuve, Belgium.
iScience
|May 7, 2024
概括
普尼克酸通过重塑脂质,诱导前列腺癌细胞中的铁亡. 酶PLA2G7,与GPX4一起,保护细胞免受这种细胞死亡途径的影响.
科学领域:
- 生物化学 生化学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 铁亡是一种受调节的细胞死亡途径,与癌症有关.
- 多不和脂肪酸可以促进癌细胞中的铁亡.
- 基酸 (PunA) 是一种联的烯酸 (CLnA),易发生过氧化.
研究的目的:
- 研究前列腺癌 (PCa) 细胞中PunA毒性的机制.
- 确定PunA在诱导铁和脂质组重塑中的作用.
- 确定影响PCa细胞对PunA敏感性的因素.
主要方法:
- 用PunA治疗PCa细胞.
- 分析脂质组重塑和铁致死诱导.
- 评估谷氨过氧化酶4 (GPX4) 和脂酶PLA2G7的表达.
- 对PLA2G7和GPX4的基因过度表达研究.
主要成果:
- PunA诱导了PCa细胞中的铁和显著的脂质组重塑.
- 抗素阴性PCa细胞对PunA表现出更大的敏感性,这与较低的GPX4表达有关.
- PLA2G7被确定为PunA诱导的铁亡的抑制剂.
- 过度表达PLA2G7降低了脂质过氧化,表明具有保护作用.
- PLA2G7和GPX4的协同过度表达赋予了强烈的保护,在抗雄激素阴性PCa细胞中对PunA进行强烈的保护.
结论:
- PLA2G7在PCa细胞中起到铁灭抑制作用,补充GPX4.4的功能.
- PLA2G7通过化含有氧化的脂物来保护PCa细胞免受CLnA诱导的铁亡.
- 针对PLA2G7和GPX4可能是PCa的治疗策略.
相关概念视频
IP3/DAG Signaling Pathway
12.0K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.0K
Phosphoinositides and PIPs
8.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K


